| fatslob-:O said: I already gave you a previous example with Gilead Sciences which is almost valued $100B in market cap and they brought a cure for Hepatitis C a little under 5 years ago which effects several dozen millions of people each year or is that somehow not "major" enough for you ? (if the drug hadn't been brought out into the market there would've been many more fatalities caused by chronic Hepatits C infections which would've developed into liver cancer and the patients at that point had to face the prospects of a compatible organ donor along with the possibility of a transplant rejection) |
Do you know what would be a lot more help for those with chronic Hepatitis C infections? If the pills didn't cost $500 to $1000 each.
Also, your lack of awareness regarding Gilead Sciences is hilariously in plain view. For you see, Gilead Sciences had nothing to do with the creation of Sovaldi. No, that drug was researched and created by Pharmasset. The only thing Gilead do was buy out Pharmasset. That's all Gilead ever does. They buy out other companies who already did the research and then gouge prices so high despite them never spending a dollar on the actual R&D.
If you want to get into the nitty gritty of this particular drug, how its actual production costs are less than 1% of the current price, how R&D was largely funded by the US government, and how little R&D Gilead actually put into the drug, do check out this article as it established a great deal of information: https://www.huffingtonpost.com/jeffrey-sachs/the-drug-that-is-bankrupt_b_6692340.html
So I do thank you for not doing hardly any research (you actually thought that Gilead brought about Sovaldi) and for highlighting yet another reason big pharma is terrible. They have other people do the research, usually with funding from the government, and then buy up those people and market the drug for pure profit.
Last edited by Megiddo - on 07 October 2018
